aTyr Pharma, Inc.ATYRNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +30.95% | +39.59% | +30.88% | +24.67% | +28.17% |
| Weighted Average Shares Diluted Growth | +30.95% | +39.59% | +30.88% | +24.67% | +28.17% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -12.27% | -28.74% | -60.10% | -69.41% | -43.09% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -26.75% | -19.75% | -14.13% | -4.16% | +16.41% |
| Book Value per Share Growth | -49.30% | -44.67% | -32.11% | -26.44% | -4.17% |
| Debt Growth | -10.83% | -12.00% | -8.04% | -8.47% | -8.92% |
| R&D Expense Growth | +43.49% | -4.13% | -11.60% | +10.10% | +49.46% |
| SG&A Expenses Growth | +101.45% | +28.42% | +12.89% | +47.49% | +44.03% |